Rachel E. Sanborn, MD

Dr. Rachel Sanborn is Medical Director of the Thoracic Oncology Program and Medical Director of the Phase I Clinical Trials Program, at the Earle A. Chiles Research Institute at Providence Cancer Institute. She treats patients with thoracic and lung cancers in Portland, OR.

After graduating from Oregon Health & Science University with her medical degree, Dr. Sanborn completed her residency in internal medicine at the University of Illinois at Chicago. Then she returned to Portland for her Fellowship in Hematology and Medical Oncology at Oregon Health & Science University. She is board certified in medical oncology and internal medicine.

Dr. Sanborn is also an Institutional Review Board Member for Providence Health and Services. She is a member of several groups, including the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, Free to Breathe, the Southwest Oncology Group Thoracic Working Group, and the Hoosier Cancer Research Network Thoracic Clinical Trial Working Group.